Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 18/20 | 0.82 |
| ▸ | PPARA | Q07869 | 18/20 | 0.82 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | RARA | P10276 | 1/20 | 0.37 |
| ▸ | RARB | P10826 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4152264 | 1.00 | PPARG (0.82) | PPARGPPARARXRARXRBRXRG | |
| SCHEMBL5317177 | 0.93 | PPARG (0.85) | PPARGPPARARXRARXRBRXRG | |
| SCHEMBL5317174 | 0.93 | PPARG (0.85) | PPARGPPARARXRARXRBRXRG | |
| SCHEMBL4152744 | 0.92 | PPARG (0.87) | PPARGPPARARXRARXRBRXRG | |
| SCHEMBL4152739 | 0.92 | PPARG (0.87) | PPARGPPARARXRARXRBRXRG | |
| SCHEMBL4144951 | 0.91 | PPARG (0.68) | PPARGPPARARARARARB | |
| SCHEMBL4156950 | 0.91 | PPARG (1.00) | PPARGPPARARXRARXRBRXRG | |
| SCHEMBL4156954 | 0.91 | PPARG (1.00) | PPARGPPARARXRARXRBRXRG | |
| SCHEMBL4151502 | 0.86 | PPARG (1.00) | PPARGPPARARXRARXRBRXRG | |
| SCHEMBL4151504 | 0.86 | PPARG (1.00) | PPARGPPARARXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090124656-A1 | Heterocyclic Oxime Compounds a Process for Their Preparation and Pharmaceutical Compositions Containing Them | LES LABORATOIRES SERVIER (FR) | 2009-05-14 | — | — | US | claimed |
| US-20090124656-A1 | Heterocyclic Oxime Compounds a Process for Their Preparation and Pharmaceutical Compositions Containing Them | LES LABORATOIRES SERVIER (FR) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124656-A1 | Heterocyclic Oxime Compounds a Process for Their Preparation and Pharmaceutical Compositions Containing Them | GPR119, HBB, CYP3A7 | PPARG 969/4885PPARA 1020/4885RXRA 585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.